Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2000
08/16/2000EP1027893A2 Alginate containing medicament and implant for treating fibrosis
08/16/2000EP1027432A2 RIBOZYMES TARGETED TO IL-15 mRNA
08/16/2000EP1027351A1 Phenanthroline derivatives
08/16/2000EP1027337A1 Integrin receptor antagonists
08/16/2000EP1027332A1 Novel lactam metalloprotease inhibitors
08/16/2000EP1027328A1 Substituted anilides
08/16/2000EP1027062A1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide
08/16/2000EP1027037A1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
08/16/2000EP1027027A2 Therapeutic method
08/16/2000CN1263522A Compounds and methods for inhibition of expression of VCAM-1
08/16/2000CN1263462A Monoesters of probucol for treatment of cardiovascular and inflammatory disease
08/16/2000CN1262954A Homothermal adhesive plaster promoting blood circulation to stop pain
08/16/2000CN1262952A Chinese herbal medicinal liquor for curing rheumatic arthritis
08/16/2000CN1055469C Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds, its preparing method and use
08/16/2000CN1055398C Medicament for curing hyerosteogeny, and its prepn. method
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103762 A biaromatic compounds in which the aromatic nuclei are connected by a propynylene or allenylene divalent radical, useful as human or veterinary medicine or used in cosmetics or keratinization disorders
08/15/2000US6103507 Protein used to raise an immunological response against a bacteria; bactericides
08/15/2000US6103491 Methods and compositions for identifying morphogen analogs
08/15/2000CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid
08/10/2000WO2000046253A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
08/10/2000WO2000046252A1 Process for cross-linking hyaluronic acid to polymers
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000WO2000046215A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000WO2000046197A1 Indole derivatives and their use as mcp-1 receptor antagonists
08/10/2000WO2000046189A1 Sulfonamide derivatives having cyclic structures
08/10/2000WO2000045848A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use
08/10/2000WO2000045836A1 Uses of thank, a tnf homologue that activates apoptosis
08/10/2000WO2000045816A1 Calcilytic compounds
08/10/2000WO2000045801A2 Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000045634A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
08/10/2000WO2000013706A8 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2361832A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use
08/10/2000CA2361589A1 Calcilytic compounds
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361407A1 Pharmaceutical compositions
08/10/2000CA2361066A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/09/2000EP1025871A1 Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
08/09/2000EP1025861A1 Pharmaceutical compositions of hydrophobically modified Hedgehog Proteins and their use
08/09/2000EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1025098A1 Benzothiophenes
08/09/2000EP1025090A1 Vitronectin receptor antagonists
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1025079A1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
08/09/2000EP1025077A1 Novel aryloxy-alkyl-dialkylamines
08/09/2000EP0642519B1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
08/09/2000EP0642513B1 Indolocarbazole imides and their use
08/09/2000CN1262625A Use of lactoferin in treatment of allergen induced disorders
08/09/2000CN1055246C Hyperosteogeny plaster
08/09/2000CN1055242C Chinese medicine for curing aseptic necrosis of head of femur
08/09/2000CN1055231C Medicine for treating hyperosteogeny disease and preparing process thereof
08/09/2000CN1055208C Medicine for bone fracture setting
08/08/2000US6100294 For treatment of metabolic, glandular, and bone disorders caused by vitamin deficiency
08/08/2000US6100282 Thiazole derivatives
08/08/2000US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
08/08/2000US6100266 Hydroxamic and carboxylic acid derivatives
08/08/2000US6100259 Cannabinoid receptor modulators
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099838 For the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases
08/05/2000CA2267049A1 Pharmaceutical compositions
08/03/2000WO2000044888A2 Dimethylarginine dimethylaminohydrolases
08/03/2000WO2000044862A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
08/03/2000WO2000044750A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND Iλ-A$g(a)
08/03/2000WO2000044749A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044739A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
08/03/2000WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044723A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
08/03/2000WO2000044722A1 Chondrongenesis promotors and indolin-2-one derivatives
08/03/2000WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044682A1 Biodegradable glass compositions and methods for radiation therapy
08/03/2000WO2000044413A1 Methods and compositions for healing and repair of articular cartilage
08/03/2000WO2000044401A1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
08/03/2000WO2000044391A2 Plasminogen kringle 4 region fragments and methods of use
08/03/2000WO2000044388A1 Modulation of immune response by ribavirin
08/03/2000WO2000044375A1 Antioxidant compositions and methods for companion animals
08/03/2000WO2000044371A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000WO2000044370A1 Drugs, foods and oral compositions containing stilbene-type compounds
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000009551A9 Human chordin-related proteins and polynucleotides encoding them
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO2000006146A9 Substituted anilide compounds and methods
08/03/2000DE19903095A1 Gewinnung von gamma-Linolensäure aus Protozoen der Gattung Colpidium Production of gamma-linolenic acid from protozoa of the genus Colpidium
08/03/2000CA2361518A1 Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha.
08/03/2000CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000CA2360690A1 Plasminogen kringle 4 region fragments and methods of use
08/03/2000CA2360674A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
1 ... 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 ... 820